IDEAYA Biosciences, Inc.
IDYA· Nasdaq
IDYAIDEAYA Biosciences, Inc.
Filed Mar 24, 2020 · 10-K · 84 days after period end · 0001564590-20-012501
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Net Income | -$10.78M | -$8.56M |
| EPS Diluted | -$0.53 | -$8.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 24, 2020 · 84 d after period end
